Marking of peripheral T-lymphocytes by retroviral transduction and transplantation of CD34+ cells in a canine X-linked severe combined immunodeficiency model

Steven E. Suter, Terry A. Gouthro, Thomas O'Malley, Brian J. Hartnett, Peter A. McSweeney, Peter F Moore, Peter J. Felsburg, Mark E. Haskins, Paula S. Henthorn

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

A retrovirus vector containing an enhanced green fluorescent protein complimentary DNA (EGFP cDNA) was used to mark and dynamically follow vector-expressing cells in the peripheral blood of bone marrow transplanted X-linked severe combined immunodeficient dogs. CD34+ cells isolated from young normal dogs were transduced, using a 2 day protocol, with an amphotropic retroviral vector that expressed enhanced green fluorescent protein (EGFP) and the canine common gamma chain (γc) cDNAs. Following transplantation of the transduced cells, normal donor peripheral blood lymphocytes (PBL) appeared by 1 month post-bone marrow transplant (BMT) and rescued three of five treated dogs from their lethal immunodeficiency. PCR and flow cytometric analysis of post-BMT PBL documented the peripheral EGFP expressing cells as CD3+ T cells, which varied from 0% to 28%. Sorting of EGFP+ and EGFP- peripheral blood T cells from two dogs, followed by vector PCR analysis, showed no evidence of vector shutdown. EGFP expression in B cells or monocytes was not detected. These marking experiments demonstrate that the transduction protocol did not abolish the lymphoid engraftment capability of ex vivo transduced canine CD34+ cells and supports the potential utility of the MSCV retroviral vector for gene transfer to XSCID affected canine hematopoietic progenitor cells (HPC).

Original languageEnglish (US)
Pages (from-to)183-196
Number of pages14
JournalVeterinary Immunology and Immunopathology
Volume117
Issue number3-4
DOIs
StatePublished - Jun 15 2007

Fingerprint

X-Linked Combined Immunodeficiency Diseases
severe combined immunodeficiency
cell transplantation
Cell Transplantation
Canidae
green fluorescent protein
T-lymphocytes
T-Lymphocytes
dogs
Dogs
retroviral vectors
Bone Marrow
bone marrow transplant
blood
Lymphocytes
Retroviridae
lymphocytes
Transplants
Polymerase Chain Reaction
cells

Keywords

  • CD34
  • Ex vivo gene therapy
  • Hematopoietic progenitor cells
  • Retroviral gene transfer

ASJC Scopus subject areas

  • Animal Science and Zoology
  • Immunology
  • veterinary(all)

Cite this

Marking of peripheral T-lymphocytes by retroviral transduction and transplantation of CD34+ cells in a canine X-linked severe combined immunodeficiency model. / Suter, Steven E.; Gouthro, Terry A.; O'Malley, Thomas; Hartnett, Brian J.; McSweeney, Peter A.; Moore, Peter F; Felsburg, Peter J.; Haskins, Mark E.; Henthorn, Paula S.

In: Veterinary Immunology and Immunopathology, Vol. 117, No. 3-4, 15.06.2007, p. 183-196.

Research output: Contribution to journalArticle

Suter, Steven E. ; Gouthro, Terry A. ; O'Malley, Thomas ; Hartnett, Brian J. ; McSweeney, Peter A. ; Moore, Peter F ; Felsburg, Peter J. ; Haskins, Mark E. ; Henthorn, Paula S. / Marking of peripheral T-lymphocytes by retroviral transduction and transplantation of CD34+ cells in a canine X-linked severe combined immunodeficiency model. In: Veterinary Immunology and Immunopathology. 2007 ; Vol. 117, No. 3-4. pp. 183-196.
@article{7ef8c096f5024782b5a67ab2dbc0b642,
title = "Marking of peripheral T-lymphocytes by retroviral transduction and transplantation of CD34+ cells in a canine X-linked severe combined immunodeficiency model",
abstract = "A retrovirus vector containing an enhanced green fluorescent protein complimentary DNA (EGFP cDNA) was used to mark and dynamically follow vector-expressing cells in the peripheral blood of bone marrow transplanted X-linked severe combined immunodeficient dogs. CD34+ cells isolated from young normal dogs were transduced, using a 2 day protocol, with an amphotropic retroviral vector that expressed enhanced green fluorescent protein (EGFP) and the canine common gamma chain (γc) cDNAs. Following transplantation of the transduced cells, normal donor peripheral blood lymphocytes (PBL) appeared by 1 month post-bone marrow transplant (BMT) and rescued three of five treated dogs from their lethal immunodeficiency. PCR and flow cytometric analysis of post-BMT PBL documented the peripheral EGFP expressing cells as CD3+ T cells, which varied from 0{\%} to 28{\%}. Sorting of EGFP+ and EGFP- peripheral blood T cells from two dogs, followed by vector PCR analysis, showed no evidence of vector shutdown. EGFP expression in B cells or monocytes was not detected. These marking experiments demonstrate that the transduction protocol did not abolish the lymphoid engraftment capability of ex vivo transduced canine CD34+ cells and supports the potential utility of the MSCV retroviral vector for gene transfer to XSCID affected canine hematopoietic progenitor cells (HPC).",
keywords = "CD34, Ex vivo gene therapy, Hematopoietic progenitor cells, Retroviral gene transfer",
author = "Suter, {Steven E.} and Gouthro, {Terry A.} and Thomas O'Malley and Hartnett, {Brian J.} and McSweeney, {Peter A.} and Moore, {Peter F} and Felsburg, {Peter J.} and Haskins, {Mark E.} and Henthorn, {Paula S.}",
year = "2007",
month = "6",
day = "15",
doi = "10.1016/j.vetimm.2007.03.004",
language = "English (US)",
volume = "117",
pages = "183--196",
journal = "Veterinary Immunology and Immunopathology",
issn = "0165-2427",
publisher = "Elsevier",
number = "3-4",

}

TY - JOUR

T1 - Marking of peripheral T-lymphocytes by retroviral transduction and transplantation of CD34+ cells in a canine X-linked severe combined immunodeficiency model

AU - Suter, Steven E.

AU - Gouthro, Terry A.

AU - O'Malley, Thomas

AU - Hartnett, Brian J.

AU - McSweeney, Peter A.

AU - Moore, Peter F

AU - Felsburg, Peter J.

AU - Haskins, Mark E.

AU - Henthorn, Paula S.

PY - 2007/6/15

Y1 - 2007/6/15

N2 - A retrovirus vector containing an enhanced green fluorescent protein complimentary DNA (EGFP cDNA) was used to mark and dynamically follow vector-expressing cells in the peripheral blood of bone marrow transplanted X-linked severe combined immunodeficient dogs. CD34+ cells isolated from young normal dogs were transduced, using a 2 day protocol, with an amphotropic retroviral vector that expressed enhanced green fluorescent protein (EGFP) and the canine common gamma chain (γc) cDNAs. Following transplantation of the transduced cells, normal donor peripheral blood lymphocytes (PBL) appeared by 1 month post-bone marrow transplant (BMT) and rescued three of five treated dogs from their lethal immunodeficiency. PCR and flow cytometric analysis of post-BMT PBL documented the peripheral EGFP expressing cells as CD3+ T cells, which varied from 0% to 28%. Sorting of EGFP+ and EGFP- peripheral blood T cells from two dogs, followed by vector PCR analysis, showed no evidence of vector shutdown. EGFP expression in B cells or monocytes was not detected. These marking experiments demonstrate that the transduction protocol did not abolish the lymphoid engraftment capability of ex vivo transduced canine CD34+ cells and supports the potential utility of the MSCV retroviral vector for gene transfer to XSCID affected canine hematopoietic progenitor cells (HPC).

AB - A retrovirus vector containing an enhanced green fluorescent protein complimentary DNA (EGFP cDNA) was used to mark and dynamically follow vector-expressing cells in the peripheral blood of bone marrow transplanted X-linked severe combined immunodeficient dogs. CD34+ cells isolated from young normal dogs were transduced, using a 2 day protocol, with an amphotropic retroviral vector that expressed enhanced green fluorescent protein (EGFP) and the canine common gamma chain (γc) cDNAs. Following transplantation of the transduced cells, normal donor peripheral blood lymphocytes (PBL) appeared by 1 month post-bone marrow transplant (BMT) and rescued three of five treated dogs from their lethal immunodeficiency. PCR and flow cytometric analysis of post-BMT PBL documented the peripheral EGFP expressing cells as CD3+ T cells, which varied from 0% to 28%. Sorting of EGFP+ and EGFP- peripheral blood T cells from two dogs, followed by vector PCR analysis, showed no evidence of vector shutdown. EGFP expression in B cells or monocytes was not detected. These marking experiments demonstrate that the transduction protocol did not abolish the lymphoid engraftment capability of ex vivo transduced canine CD34+ cells and supports the potential utility of the MSCV retroviral vector for gene transfer to XSCID affected canine hematopoietic progenitor cells (HPC).

KW - CD34

KW - Ex vivo gene therapy

KW - Hematopoietic progenitor cells

KW - Retroviral gene transfer

UR - http://www.scopus.com/inward/record.url?scp=34247891444&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247891444&partnerID=8YFLogxK

U2 - 10.1016/j.vetimm.2007.03.004

DO - 10.1016/j.vetimm.2007.03.004

M3 - Article

C2 - 17442404

AN - SCOPUS:34247891444

VL - 117

SP - 183

EP - 196

JO - Veterinary Immunology and Immunopathology

JF - Veterinary Immunology and Immunopathology

SN - 0165-2427

IS - 3-4

ER -